IRIS
POLLICINO, Teresa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.484
NA - Nord America 5.899
AS - Asia 3.149
SA - Sud America 1.020
AF - Africa 93
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.660
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.782
RU - Federazione Russa 3.214
SG - Singapore 1.237
CN - Cina 979
BR - Brasile 909
IE - Irlanda 779
SE - Svezia 706
IT - Italia 456
HK - Hong Kong 370
DE - Germania 303
FR - Francia 203
FI - Finlandia 186
PL - Polonia 181
UA - Ucraina 179
VN - Vietnam 168
GB - Regno Unito 115
IN - India 92
CA - Canada 52
BD - Bangladesh 48
MX - Messico 42
IQ - Iraq 37
TR - Turchia 36
BE - Belgio 33
AR - Argentina 31
ZA - Sudafrica 29
ID - Indonesia 26
ES - Italia 23
NL - Olanda 23
JP - Giappone 22
PK - Pakistan 21
CZ - Repubblica Ceca 20
AT - Austria 19
CO - Colombia 19
MA - Marocco 18
UZ - Uzbekistan 18
EC - Ecuador 15
KE - Kenya 11
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
VE - Venezuela 10
JO - Giordania 8
NZ - Nuova Zelanda 8
PE - Perù 8
TN - Tunisia 8
GR - Grecia 7
LT - Lituania 7
NP - Nepal 7
SA - Arabia Saudita 7
AZ - Azerbaigian 6
BO - Bolivia 6
CI - Costa d'Avorio 6
CL - Cile 6
HN - Honduras 6
KG - Kirghizistan 6
LB - Libano 6
MY - Malesia 6
PH - Filippine 6
BG - Bulgaria 5
EG - Egitto 5
UY - Uruguay 5
AL - Albania 4
AU - Australia 4
CH - Svizzera 4
GT - Guatemala 4
IR - Iran 4
JM - Giamaica 4
OM - Oman 4
AO - Angola 3
DZ - Algeria 3
IL - Israele 3
KZ - Kazakistan 3
PS - Palestinian Territory 3
SN - Senegal 3
SV - El Salvador 3
BY - Bielorussia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
KR - Corea 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
MN - Mongolia 2
PT - Portogallo 2
QA - Qatar 2
AM - Armenia 1
BN - Brunei Darussalam 1
BW - Botswana 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
KW - Kuwait 1
LU - Lussemburgo 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
Totale 16.651
Salva come PNG Salva come JPEG
Città #
Ashburn 1.382
Moscow 975
Dublin 779
Dallas 723
Singapore 719
Chandler 543
Nyköping 408
Jacksonville 371
Hong Kong 370
Beijing 356
San Jose 279
Messina 259
Warsaw 167
Los Angeles 144
The Dalles 142
Princeton 119
Ann Arbor 117
Munich 106
Lauterbourg 102
Medford 98
Cambridge 90
Des Moines 84
São Paulo 75
New York 69
Ho Chi Minh City 66
Boardman 63
Dearborn 51
Council Bluffs 50
Helsinki 47
Houston 46
Buffalo 43
Jinan 41
Turku 40
Frankfurt am Main 37
Wilmington 36
Woodbridge 36
Brussels 32
Orem 32
Tianjin 32
Hanoi 31
Santa Clara 31
Brasília 30
Belo Horizonte 29
Guangzhou 29
Pune 28
Redondo Beach 27
San Mateo 27
Chennai 22
Rio de Janeiro 22
Falls Church 21
Nanjing 21
Phoenix 21
Shanghai 21
Tokyo 21
Shenzhen 19
Boston 18
Brooklyn 18
Stockholm 18
Zhengzhou 18
Jakarta 17
Nuremberg 17
Rome 17
Tashkent 17
Atlanta 16
Dong Ket 16
Johannesburg 16
Mexico City 16
Chicago 15
Shenyang 15
London 14
Montreal 14
Porto Alegre 14
Rosolini 14
Baghdad 13
Brno 13
Hebei 13
Amsterdam 12
Lahore 12
Lappeenranta 12
San Francisco 12
Seattle 12
Denver 11
Manchester 11
Norwalk 11
Salvador 11
Dhaka 10
Düsseldorf 10
Guarulhos 10
Haiphong 10
Mumbai 10
Poplar 10
Catania 9
Fortaleza 9
Haikou 9
Hangzhou 9
Nairobi 9
Curitiba 8
Goiânia 8
Ottawa 8
Tappahannock 8
Totale 10.099
Salva come PNG Salva come JPEG
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 382
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 273
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 264
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 256
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 228
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 221
Risk Factors Associated with NASH in Obese Patients Undergoing Bariatric Surgery NASH and bariatric surgery 216
A combination of different diagnostic tools allows identification of inactive hepatitis B virus carriers at a single time point evaluation 212
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 210
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 209
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 202
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. 198
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 198
Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy 192
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 189
Control of cccDNA function in hepatitis B virus infection. 189
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 187
Cirrhosis related to wild-type HBV infection in siblings with A3 - B35 - Cw4 HLA class I phenotype. 184
[A glance into the past ... Southern and northern blot: really superseded?] 181
Mitochondrial DNA is a target of HBV integration 180
Analysis of HBV integration in mitochondrial DNA of HepAD38 cells by the high-throughput HBV integration sequencing and RNASeq approaches 179
Is there a downgrading in the alert about the hepatitis B virus infection in Italy? 176
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 176
Human hepatitis B virus negatively impacts the protective immune cross-talk between natural killer and dendritic cells 175
A 2010 update on occult hepatitis B infection. 174
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 170
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 170
Co-circulation of SARS-CoV-2 Alpha and Gamma variants in Italy, February and March 2021 170
Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice 169
Clinical virology of hepatitis B virus infection 168
Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 167
Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones 167
Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. 167
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis? 164
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 162
Conserved transactivating and pro-apoptotic functions of hepadnaviral X protein in ortho- and avihepadnaviruses. 161
Flavocoxid exerts a potent antiviral effect against hepatitis B virus. 161
Hepatitis B e antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection. 159
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 155
Disease progression and liver cancer in the ferroportin disease. 155
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 155
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 154
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 (IL8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY 152
Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. 151
Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells. 150
Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8Production which in Turn Inhibits Interferon-alfa Antiviral Activity 150
High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy. 149
Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis. 147
Obesity and liver cancer 147
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 146
A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook 145
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 145
The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. 144
NS3 genetic variability in hepatitis C virus genotype-1b isolates from liver specimens and blood samples of treatment naïve patients with chronic hepatitis C 144
Assessing Genomic Mutations in SARS-CoV-2: Potential Resistance to Antiviral Drugs in Viral Populations from Untreated COVID-19 Patients 143
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 N(IL-8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INERFERON ALFA ANTIVIRAL ACITIVITY 141
Molecular analyses of TT virus in paired and tissue samples from 150 patients with either hepatic or non-hepatic disease 140
Ficolin-2 Plasma Level Assesses Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 138
Virological profiles in hepatitis B virus inactive carriers: monthly evaluation in 1-year follow-up study 135
Assessing immunological and virological responses in the liver: implications for the cure of chronic hepatitis B virus infection 134
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 PRODUCTION WHICH IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY IN HEPATOMA CELL LINES 133
Impact of Occult Hepatitis B Virus Infection on the Outcome of Chronic Hepatitis C. 133
Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications. 130
Update of the statements on biology and clinical impact of occult hepatitis B virus infection 129
Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo 128
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 128
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 127
PRE-S GENETIC VARIANTS ARE HIGHLY PREVALENT AND SIGNIFICANTLY CORRELATE WITH LOWER LEVELS OF HBSAG IN ACTIVE HBV INFECTIONS 126
Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. 124
FULMINANT-HEPATITIS ASSOCIATED WITH THE INTRAFAMILIAR SPREAD OF A PRE-S2 DEFECTIVE HBV VARIANT AND THE LATE EMERGENCE OF HBEAG- MINUS VIRAL STRAINS 123
Targeting Hepatitis B virus infected cells with a T-cell receptor like antibody 123
Occult hepatitis B virus in liver tissue of individuals without hepatic disease. 120
Severe outcome of hepatitis B virus (HBV) infection and lack of HBV e antigen-defective virus emergence in patients homozygous for HLA class I alleles. 117
Statements from the Taormina expert meeting on occult hepatitis B virus infection. 115
Long-term virological and clinical evaluation of chronic hepatitis B patients under nucleos(t)ide analogues therapy 113
Evaluation of hepatitis B and C virus infections in patients with non-Hodgkin's lymphoma and without liver disease 113
Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. 113
Occult hepatitis B virus infection in hepatitis C virus negative chronic liver diseases 113
Occult HBV infection 112
Integration of hepatitis B virus DNA in chronically infected patients assessed by Alu-PCR. 112
Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. 111
Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance 111
NS3 Q80K Polymorphism in viral isolates from Liver Tissues and serum samples of naive HCV genotype 1a Patients 110
Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure 108
Occult hepatitis B virus infection 107
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. 107
Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. 107
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3 infected patients within the Italian network VIRONET-C 107
HBV-integration studies in the clinic: Role in the natural history of infection 107
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease 101
Hepatitis Delta Virus and Hepatocellular Carcinoma 100
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 97
Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma 95
Pro-apoptotic effect of the hepatitis B virus X gene. 93
Hepatitis B viral replication influences the expression of natural killer cell ligands 93
Occult hepatitis B virus infection: an update 92
Transcriptional regulation of miR-224 upregulated in human HCCs by NFκB inflammatory pathways. 92
The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver. 91
p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. 91
Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. 91
Totale 15.069
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.629
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.629
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202150 0 0 0 0 0 0 0 0 0 0 0 50
2021/2022745 7 57 27 30 57 16 63 33 18 99 99 239
2022/20232.196 164 250 104 176 138 224 45 100 906 14 61 14
2023/2024719 50 111 26 61 41 103 2 228 3 23 20 51
2024/20252.658 47 19 80 227 115 121 137 519 554 150 228 461
2025/20268.366 360 649 611 546 700 1.592 1.013 1.020 1.103 399 181 192
Totale 16.880